Presenter: Dr G Santhi priya
Moderator: Dr Rajeev
Contents
1. Introduction and development
2. Hematopoiesis
3. Cytokines and the Control of Hematopoiesis
4. Cytokine Receptors, Signaling Pathways, and Transcription Factors
5. Hematopoietic Microenvironment
6. References
• The pioneering work of Till and McCulloch began to
define the hierarchy of hematopoietic precursor cells
using in vivo clonal assays.
• Hematopoietic stem cells (HSCs) develop in discrete
anatomical niches, migrating during embryogenesis from
the aorta-gonadmesonephros (AGM) region to the fetal
liver, and finally to the bone marrow, where most HSCs
reside throughout adult life.
1. Introduction and development
2. Hematopoiesis
•Defination :“The processes involved in the production of all of
the various cells of the blood from the HSCs are collectively
called hematopoiesis”
•Highly regulated process to maintain circulating cell numbers
within relatively constant levels and to respond rapidly to
conditions requiring extra cells .
•Maintains balance between self renewal, terminal differentiation,
migration, and cell death.
Sites of hematopoiesis
Hematopoietic cells
Stem Cells
• Multipotential precursors
• Stem Cell Phenotype:
CD34+Thy-1+CD49f +CD38-Lin-HLADR-Rh123Lo
The Stem Cell Compartment
“age hierarchy”
long-term repopulating cells (LTRs)
short-term repopulating cells (STRs)
Stem Cell Niches
• Ligand signaling pathway
• Growth factor receptor interactions
Progenitor Cells
•Populations of differentiating cells that have an increasingly limited capacity
to self-renew and are gradually more restricted in differentiation options.
•Lineage-specific transcription factors are thought to play essential roles in this
process
3. Cytokines and the Control of Hematopoiesis
Growth factors / Cytokines
3. Cytokines and the Control of Hematopoiesis
Growth factors / Cytokines
Early-Acting (Multilineage) Growth Factors Stem Cell Factor (SCF)
Flt3 Ligand (FL)
Interleukin 3
GM-CSF
Interleukin 6
Interleukin 11
Later-Acting (Lineage-Restricted) Growth G-CSF
Factors M-CSF
EPO
Indirect-Acting Growth Factors TPO
Other Stem Cell Regulators IL-5
IL-2,-4, -7, -10, -12, -13, -14, -15
4. Cytokine Receptors, Signaling Pathways, and Transcription Factors
Cytokine Receptors: homodimers/ heterodimers or heterotrimers
Receptors with Intrinsic Tyrosine Kinase Domains
Hematopoietic Growth Factor Receptor Superfamily
Receptor Functional Domains
Signaling Pathways
Transcription Factors
•TFs associated with the activation of a particular lineage-specific
differentiation program often simultaneously inhibit alternate lineage-specific
transcription factors.
•Interestingly, more than half of the hematopoietic transcription factors
identified have been shown to be dysregulated in hematologic malignancies
(translocations, point mutations of TF genes)
•Thus, the impaired differentiation seen in leukemia is likely due to
abnormalities of critical, discrete pathways of transcriptional control.
Clinical Use of Hematopoietic Growth Factors
5.Hematopoietic microenvironment
5.Hematopoietic microenvironment
HSC niche players in the adult bone marrow
The aging HSC niche
• McKenzie SB, Williams JL. Hematopoiesis.In: Clinical labouratory
hematology, 3rd ed.Pearson;2016 p71-91.
•Singh T. Normal hematopoiesis and evaluation of bone marrow and
peripheral blood film. In: Atlas and Text of Haematology,3rd ed.Delhi:2014.P.1-
4
•Diseases of white blood cells, lymph nodes,spleen and thymus. In Kumar V,
Abbas A K, Aster J C, Robbins and cotran patholology basis of disease. 9th ed.
Elsevier Inc: 2016. P.579-82.
References
• Gao X, Xu C, Asada N, Frenette PS. The hematopoietic stem cell niche: from
embryo to adult. Development 2018;145:1-12
• Laffan M A, Manning R , Investigation of hemostasis, Bain B.J, Bates I, Laffan
M.A, Lewis S.M, Dacie and Lewis Practical Haematology. 11th ed. London:
2012. P.424-39
• Mathur SC,Hutchison RE,Mahi G. Hematopoiesis .In Bain B.J, Bates I, Laffan
M.A, Lewis S.M, Dacie and Lewis Practical Haematology. 11th ed. London:
2012. P.540-58
References
Thank you!!!

7. hematopoiesis

  • 1.
    Presenter: Dr GSanthi priya Moderator: Dr Rajeev
  • 2.
    Contents 1. Introduction anddevelopment 2. Hematopoiesis 3. Cytokines and the Control of Hematopoiesis 4. Cytokine Receptors, Signaling Pathways, and Transcription Factors 5. Hematopoietic Microenvironment 6. References
  • 3.
    • The pioneeringwork of Till and McCulloch began to define the hierarchy of hematopoietic precursor cells using in vivo clonal assays. • Hematopoietic stem cells (HSCs) develop in discrete anatomical niches, migrating during embryogenesis from the aorta-gonadmesonephros (AGM) region to the fetal liver, and finally to the bone marrow, where most HSCs reside throughout adult life. 1. Introduction and development
  • 5.
    2. Hematopoiesis •Defination :“Theprocesses involved in the production of all of the various cells of the blood from the HSCs are collectively called hematopoiesis” •Highly regulated process to maintain circulating cell numbers within relatively constant levels and to respond rapidly to conditions requiring extra cells . •Maintains balance between self renewal, terminal differentiation, migration, and cell death.
  • 6.
  • 7.
  • 8.
    Stem Cells • Multipotentialprecursors • Stem Cell Phenotype: CD34+Thy-1+CD49f +CD38-Lin-HLADR-Rh123Lo
  • 10.
    The Stem CellCompartment “age hierarchy” long-term repopulating cells (LTRs) short-term repopulating cells (STRs)
  • 11.
    Stem Cell Niches •Ligand signaling pathway • Growth factor receptor interactions
  • 12.
    Progenitor Cells •Populations ofdifferentiating cells that have an increasingly limited capacity to self-renew and are gradually more restricted in differentiation options. •Lineage-specific transcription factors are thought to play essential roles in this process
  • 15.
    3. Cytokines andthe Control of Hematopoiesis Growth factors / Cytokines
  • 17.
    3. Cytokines andthe Control of Hematopoiesis Growth factors / Cytokines Early-Acting (Multilineage) Growth Factors Stem Cell Factor (SCF) Flt3 Ligand (FL) Interleukin 3 GM-CSF Interleukin 6 Interleukin 11 Later-Acting (Lineage-Restricted) Growth G-CSF Factors M-CSF EPO Indirect-Acting Growth Factors TPO Other Stem Cell Regulators IL-5 IL-2,-4, -7, -10, -12, -13, -14, -15
  • 18.
    4. Cytokine Receptors,Signaling Pathways, and Transcription Factors Cytokine Receptors: homodimers/ heterodimers or heterotrimers Receptors with Intrinsic Tyrosine Kinase Domains Hematopoietic Growth Factor Receptor Superfamily Receptor Functional Domains
  • 19.
  • 21.
    Transcription Factors •TFs associatedwith the activation of a particular lineage-specific differentiation program often simultaneously inhibit alternate lineage-specific transcription factors. •Interestingly, more than half of the hematopoietic transcription factors identified have been shown to be dysregulated in hematologic malignancies (translocations, point mutations of TF genes) •Thus, the impaired differentiation seen in leukemia is likely due to abnormalities of critical, discrete pathways of transcriptional control.
  • 22.
    Clinical Use ofHematopoietic Growth Factors
  • 23.
  • 24.
  • 25.
    HSC niche playersin the adult bone marrow
  • 26.
  • 27.
    • McKenzie SB,Williams JL. Hematopoiesis.In: Clinical labouratory hematology, 3rd ed.Pearson;2016 p71-91. •Singh T. Normal hematopoiesis and evaluation of bone marrow and peripheral blood film. In: Atlas and Text of Haematology,3rd ed.Delhi:2014.P.1- 4 •Diseases of white blood cells, lymph nodes,spleen and thymus. In Kumar V, Abbas A K, Aster J C, Robbins and cotran patholology basis of disease. 9th ed. Elsevier Inc: 2016. P.579-82. References
  • 28.
    • Gao X,Xu C, Asada N, Frenette PS. The hematopoietic stem cell niche: from embryo to adult. Development 2018;145:1-12 • Laffan M A, Manning R , Investigation of hemostasis, Bain B.J, Bates I, Laffan M.A, Lewis S.M, Dacie and Lewis Practical Haematology. 11th ed. London: 2012. P.424-39 • Mathur SC,Hutchison RE,Mahi G. Hematopoiesis .In Bain B.J, Bates I, Laffan M.A, Lewis S.M, Dacie and Lewis Practical Haematology. 11th ed. London: 2012. P.540-58 References
  • 29.